Endovenous Laser Ablation for Superficial Venous Reflux and Varicose Veins: Scoping Review with ☸️SAIMSARA.

Name: SAIMSARA Evidence Object vascular::EVLA_PM
Creator: SAIMSARA
License: https://saimsara.com/license/

SAIMSARA

doi:10.62487/saimsaraa7dba350

SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Endovenous Laser Ablation for Superficial Venous Reflux and Varicose Veins: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

Chat with this issue

DOI: 10.62487/saimsaraa7dba350

Editorial note

• Last update: 2026-05-31 10:58:01

What is this paper about

EVLA is no longer just an alternative to stripping—it has become a central treatment platform for superficial venous reflux. This scoping review maps 196 references and 361 original studies, showing strong closure performance, faster recovery, and durable benefit across GSV, SSV, accessory, perforator, and ulcer-related venous disease. The full paper goes beyond “EVLA works” and explains where outcomes depend on wavelength, fiber design, energy delivery, adjunctive treatment, thrombosis risk, and long-term recurrence.

Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.

Generated with SAIMSARA v4.9

Abstract: To synthesize the structured evidence on endovenous laser ablation (EVLA), emphasizing its effectiveness, safety, mechanisms, procedural optimization, comparative performance, and clinical implementation across venous disease contexts. The review uses 196 references and builds its evidence map from 361 original studies with 909189 total participants/sample observations (topic-deduplicated ΣN). The mapped evidence indicates that EVLA is a durable, minimally invasive cornerstone for treating superficial venous reflux, with high anatomical closure, faster recovery than open surgery, and favorable long-term outcomes against foam sclerotherapy and mechanochemical ablation, including 91% versus 47% occlusion at 5 years in one randomized comparison. The dominant signal supports EVLA as effective across great and small saphenous, accessory, and perforator territories, while highlighting that outcomes are shaped by wavelength, fiber design, energy delivery, and adjunctive tributary management. Long-term recurrence remains the principal uncertainty, with clinical recurrence approaching half of patients by 10 years in some cohorts, and complications such as endovenous heat-induced thrombosis (EHIT), paresthesia, and rare pulmonary embolism warrant continued vigilance. Future research should prioritize harmonized long-term registries and head-to-head trials of contemporary wavelengths and fibers using standardized recurrence, pain, and patient-reported endpoints.

Keywords: Endovenous laser ablation; Varicose veins; Great saphenous vein; Venous insufficiency; Laser therapy; Vein occlusion; Clinical recurrence; Quality of life; Postoperative complications; Tumescent anesthesia

Review Stats

Final search date and database lock: 2026-05-22 07:17:42 CEST
Plan: Pro (expanded craft tokens; source: PubMed)
Source: PubMed
Total Abstracts/Papers: 477
Downloaded Abstracts/Papers: 477
Included original and non-original Abstracts/Papers (all): 436
Included original Abstracts/Papers (Vote counting by direction of effect): 361
Reference Index (links used in paper): 196
Total participants/sample observations (topic deduplicated ΣN): 909189

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (196)

[1] The role of compression therapy after endovenous laser ablation (EVLA) - review. — https://doi.org/10.5604/01.3001.0053.9855
[2] Third generation of laser (>1900) for endovenous thermoablation (EVLA) of varicose veins: A systematic review and meta-analysis. — https://doi.org/10.1177/02683555241227017
[3] Ten-year outcomes of a randomized clinical trial of endothermal ablation versus conventional surgery for great saphenous varicose veins. — https://doi.org/10.1093/bjs/znae195
[4] Technical Efficacy and Safety of Outpatient Endovenous Laser Ablation of Varicose Veins Under Local Anesthesia. — https://doi.org/10.2147/vhrm.s518681
[5] Editor's Choice - A Randomised, Single Blind, Controlled Trial Comparing Flush Endovenous Laser Ablation with Standard Endovenous Laser Ablation of the Great Saphenous Vein. — https://doi.org/10.1016/j.ejvs.2025.01.014
[6] Comparative study between endovenous laser ablation (EVLA) with 1940 nm versus EVLA with 1470 nm for treatment of incompetent great saphenous vein and short saphenous vein: A randomized controlled trial. — https://doi.org/10.1016/j.jvsv.2024.101960
[7] Endovenous laser ablation (EVLA) 980 nm versus 1470 nm and the impact of fiber type: a systematic review and meta-analysis. — https://doi.org/10.1007/s10103-024-04112-0
[8] Editor's Choice - Five Year Follow Up of a Randomised Clinical Trial of Endovenous Laser Ablation versus Mechanochemical Ablation for Superficial Venous Incompetence (LAMA trial). — https://doi.org/10.1016/j.ejvs.2025.04.038

Unlock the full paper to view the complete Reference Index.